Clinical Trials on Corynebacterium Infections

Total 56869 results

Sanofi Pasteur, a Sanofi Company

Completed

Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age

Pertussis | Tetanus | Diphtheria | Meningitis | Meningococcal Infection | Haemophilus Influenzae Serotype b (Hib)

United States, Puerto Rico
GlaxoSmithKline

Completed

Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years

Tetanus | Diphtheria | Acellular Pertussis

United States
Sanofi

Completed

Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines

Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Influenzae Type B

Philippines
ABO Holdings, Inc.

Active, not recruiting

Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors

Tetanus, Diphtheria and Acellular Pertussis Vaccination

United States
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060)

Rotavirus Disease
Green Cross Corporation

Unknown

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults

Whooping Cough | Tetanus | Diphtheria

Korea, Republic of
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine

Tetanus | Diphtheria | Acellular Pertussis | Haemophilus Influenzae Type b

China
GlaxoSmithKline

Completed

Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age

Tetanus | Diphtheria | Acellular Pertussis | Haemophilus Influenzae Type b

China
University of Colorado, Denver
Centers for Disease Control and Prevention

Completed

Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients

Meningococcal Infection | Varicella | Human Papilloma Virus (HPV) | Tetanus-diphtheria-acellular Pertussis (Tdap)
Sanofi Pasteur, a Sanofi Company

Completed

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

A Study to Assess the Safety of Adacel® Vaccine

Pertussis | Tetanus | Diphtheria

Vietnam
Sanofi

Completed

Study of Adacel® Vaccine Administered to Persons 10 Years of Age

Pertussis | Tetanus | Diphtheria

United States
Sanofi

Active, not recruiting

Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy

Pertussis (Whooping Cough)

France
Sanofi Pasteur, a Sanofi Company

Completed

Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age

Pertussis | Diphtheria

Canada
JN-International Medical Corporation

Completed

Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Meningococcal Infections | Meningococcal Meningitis

United States
LG Chem

Unknown

A Phase IV Study to Assess the Safety of EupentaTM Inj

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type B Infection
GlaxoSmithKline

Completed

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

Tetanus | Diphtheria | Acellular Pertussis

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose

Pertussis | Whooping Cough | Tetanus | Diphtheria

United States, Canada
National Institute of Allergy and Infectious Diseases...

Completed

Tdap Vaccine in Post-Partum Women

Pertussis | Tetanus | Diphtheria

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan

Pertussis | Tetanus | Diphtheria

Taiwan
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®

Pertussis | Tetanus | Diphtheria

United States
Sanofi Pasteur, a Sanofi Company

Completed

Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.

Pertussis | Tetanus | Diphtheria

China
National Institute of Allergy and Infectious Diseases...

Completed

Pertussis Vaccine in Healthy Pregnant Women

Pertussis | Tetanus | Diphtheria

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age

Pertussis | Tetanus | Diphtheria

United States, Canada
Jiangsu Province Centers for Disease Control and...

Completed

Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants

Pertussis

China
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immune Response of Different Pediatric Combination Vaccines.

Pertussis | Diphtheria | Polio

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam

Meningitis | Meningococcal Infections | Meningococcal Meningitis

Vietnam
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects

Meningitis | Meningococcal Infections | Meningococcal Meningitis

Japan
Centers for Disease Control and Prevention
Bill and Melinda Gates Foundation; Ministry of Health, Uganda; African Field... and other collaborators

Completed

Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda

Hepatitis B | Measles | Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Influenzae Type b Infection
GlaxoSmithKline

Completed

Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.

Tetanus | Diphtheria | Acellular Pertussis

Germany
Sanofi Pasteur, a Sanofi Company

Completed

Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China

Pertussis | Tetanus | Diphtheria | Polio

China
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China

Pertussis | Tetanus | Diphtheria

China
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents

Pertussis | Whooping Cough | Tetanus | Diphtheria

United States
GlaxoSmithKline

Completed

Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults

Pertussis | Tetanus | Diphtheria
Sanofi Pasteur, a Sanofi Company

Completed

Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease

Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Infections

United States
Sanofi Pasteur, a Sanofi Company

Completed

Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children

Diphtheria, Tetanus and Pertussis

Spain
GlaxoSmithKline

Completed

Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine

Diphteria, Tetanus and Pertussis
GlaxoSmithKline
Optum, Carolyn Martin and Ami Buikema

Completed

Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants

Tetanus | Diphtheria | Acellular Pertussis
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants

Rotavirus

Japan
GlaxoSmithKline

Terminated

Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia

Diphtheria-Tetanus-Acellular Pertussis

Colombia
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years

Tetanus | Diphtheria | Acellular Pertussis

United States
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.

Tetanus | Diphtheria | Acellular Pertussis

Finland
Sanofi Pasteur, a Sanofi Company

Completed

Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

Tetanus | Diphtheria | Poliomyelitis

France
GlaxoSmithKline

Completed

Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®

Tetanus | Diphtheria | Acellular Pertussis
GlaxoSmithKline

Completed

Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine

Tetanus | Diphtheria | Acellular Pertussis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants

Pertussis | Tetanus | Diphtheria | Diphtheria Immunisation | Tetanus Immunisation | Clostridium Difficile Immunisation

Mali
Sanofi

Completed

Immunogenicity and Safety of Pentaxim™ in an Indian Population

Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Infections

India
CanSino Biologics Inc.

Active, not recruiting

A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)

Diphtheria, Tetanus and Acellular Pertussis

China
GlaxoSmithKline

Completed

Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea

Diphtheria-Tetanus-acellular Pertussis Vaccines

Korea, Republic of
Women and Infants Hospital of Rhode Island

Not yet recruiting

Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy (ITAPP)

Vaccine Exposure During Pregnancy | Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination | Non-birthing Partner Vaccination in Pregnancy

Clinical Trials on Corynebacterium Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations